Carcinoid syndrome classification: Difference between revisions

	Carcinoid syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Carcinoid Syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Carcinoid syndrome classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Carcinoid syndrome classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Carcinoid syndrome classification
CDC on Carcinoid syndrome classification
Carcinoid syndrome classification in the news
Blogs on Carcinoid syndrome classification
Directions to Hospitals Treating Carcinoid syndrome
Risk calculators and risk factors for Carcinoid syndrome classification

VisualWikitext

Latest revision as of 20:04, 1 May 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Anum Gull M.B.B.S.[2]Parminder Dhingra, M.D. [3]

Overview

Gastroenteropancreatic neuroendocrine tumors are classified based on their origin from the embryonic divisions of the alimentary tract into foregut (bronchial, stomach), midgut (small intestine, appendix, cecum) and hindgut (distal colon, rectum, genitourinary) tumours.

Classification

Gastroentero-pancreatic neuroendocrine tumors are classified based on their origin from the embryonic divisions of the alimentary tract:

Foregut (bronchial, stomach)
Midgut (small intestine, appendix, cecum)
Hindgut (distal colon, rectum, genitourinary)

Gasroenteropancreatic- neuroendocrine tumor produce a number of secretory products, resulting in a wide range of clinical symptoms.^[1] ^[2]^[3]
Midgut gastrointestinal tract neuroendocrine tumors produce serotonin and other vasoactive substances that causes the manifestations of typical carcinoid syndrome.
Lung neuroendocrine tumors produce less quantities of serotonin.
Carcinoid syndrome is caused less commonly by lung neuroendocrine tumor and most often by tumors of large size (>5 cm).

Gastroenteropancreatic neuroendocrine tumors
	Foregut	Midgut	Hindgut
Location	Stomach Duodenum Bronchus Thymus	Jejunum Ileum Appendix Ascending colon	Transverse colon Descending colon Sigmoid colon Rectum Genitourinary
Hormones produced	5-hydroxytryptophan Histamine Multiple polypeptides	Serotonin Prostaglandins Polypeptides	Variable
Possibility of carcinoid syndrome	Rare, and atypical when it occurs	Classic	Rare

References

↑ Büyükaşık K, Arı A, Tatar C, Akçe B, Sevinç MM, Sarı S, Paşaoğlu E, Bektaş H (2017). "Clinicopathological features of gastroenteropancreatic neuroendocrine tumors: A retrospective evaluation of 42 cases". Turk J Surg. 33 (4): 279–283. doi:10.5152/UCD.2017.3685. PMID 29260133.
↑ Davies L, Weickert MO (2016). "Gastroenteropancreatic neuroendocrine tumours: an overview". Br J Nurs. 25 (4): S12–5. doi:10.12968/bjon.2016.25.4.S12. PMID 26911175.
↑ Oberg K, Castellano D (March 2011). "Current knowledge on diagnosis and staging of neuroendocrine tumors". Cancer Metastasis Rev. 30 Suppl 1: 3–7. doi:10.1007/s10555-011-9292-1. PMID 21311954.

Template:WH Template:WS

[pmid29260133-1] Büyükaşık K, Arı A, Tatar C, Akçe B, Sevinç MM, Sarı S, Paşaoğlu E, Bektaş H (2017). "Clinicopathological features of gastroenteropancreatic neuroendocrine tumors: A retrospective evaluation of 42 cases". Turk J Surg. 33 (4): 279–283. doi:10.5152/UCD.2017.3685. PMID 29260133.

[pmid26911175-2] Davies L, Weickert MO (2016). "Gastroenteropancreatic neuroendocrine tumours: an overview". Br J Nurs. 25 (4): S12–5. doi:10.12968/bjon.2016.25.4.S12. PMID 26911175.

[pmid21311954-3] Oberg K, Castellano D (March 2011). "Current knowledge on diagnosis and staging of neuroendocrine tumors". Cancer Metastasis Rev. 30 Suppl 1: 3–7. doi:10.1007/s10555-011-9292-1. PMID 21311954.

[1]

[2]

[3]

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Carcinoid syndrome}}
-{{CMG}}{{AE}}{{PSD}}
+{{CMG}}{{AE}}{{Anum}}{{PSD}}
 ==Overview==
-Based on the location of tumor, carcinoid tumor may be classified into either [[foregut]], [[midgut]], or [[hindgut]] carcinoid tumors.
+[[Gastroenteropancreatic]] [[neuroendocrine tumors]] are classified based on their origin from the [[embryonic]] divisions of the [[alimentary tract]] into [[foregut]] [[Bronchial|(bronchial]], [[stomach]]), [[midgut]] ([[small intestine]], [[appendix]], [[cecum]]) and [[hindgut]] ([[Colon|distal colon]], [[rectum]], [[genitourinary]]) [[Tumour|tumours.]]
 ==Classification==
-===1. Carcinoid tumor in the gastrointestinal tract===
+*[[Gastroenterology|Gastroentero]]-[[pancreatic]] [[Neuroendocrine tumor|neuroendocrine tumors]] are classified based on their origin from the [[embryonic]] divisions of the [[alimentary tract]]:
-====Based on the location in the primitive gut====
+#[[Foregut]] [[Bronchial|(bronchial]], [[stomach]])
-Carcinoid tumor of the gastrointestinal tract may be classified based on the location in the primitive gut into three subtypes:
+#[[Midgut]] ([[small intestine]], [[appendix]], [[cecum]])
-*[[Foregut]] carcinoid tumors
+#[[Hindgut]] ([[Colon|distal colon]], [[rectum]], [[genitourinary]])
-*[[Midgut]] carcinoid tumors
+*Gasroenteropancreatic- [[neuroendocrine tumor]] produce a number of [[Secretory component|secretory]] products, resulting in a wide range of clinica[[Symptoms|l symptoms.]]<ref name="pmid29260133">{{cite journal |vauthors=Büyükaşık K, Arı A, Tatar C, Akçe B, Sevinç MM, Sarı S, Paşaoğlu E, Bektaş H |title=Clinicopathological features of gastroenteropancreatic neuroendocrine tumors: A retrospective evaluation of 42 cases |journal=Turk J Surg |volume=33 |issue=4 |pages=279–283 |date=2017 |pmid=29260133 |doi=10.5152/UCD.2017.3685 |url=}}</ref> <ref name="pmid26911175">{{cite journal |vauthors=Davies L, Weickert MO |title=Gastroenteropancreatic neuroendocrine tumours: an overview |journal=Br J Nurs |volume=25 |issue=4 |pages=S12–5 |date=2016 |pmid=26911175 |doi=10.12968/bjon.2016.25.4.S12 |url=}}</ref><ref name="pmid21311954">{{cite journal |vauthors=Oberg K, Castellano D |title=Current knowledge on diagnosis and staging of neuroendocrine tumors |journal=Cancer Metastasis Rev. |volume=30 Suppl 1 |issue= |pages=3–7 |date=March 2011 |pmid=21311954 |doi=10.1007/s10555-011-9292-1 |url=}}</ref>
-*[[Hindgut]] carcinoid tumors
+*[[Midgut]] [[gastrointestinal]] tract [[neuroendocrine tumor|neuroendocrine tumors]] produce [[serotonin]] and other [[vasoactive]] [[substances]] that causes the manifestations of typical [[Carcinoid Syndrome|carcinoid syndrome.]]
+*[[Lung]] [[neuroendocrine tumors]] produce less quantities of [[serotonin]].
+*[[Carcinoid Syndrome|Carcinoid syndrome]] is caused less commonly by [[lung]] [[neuroendocrine tumor]]  and most often by [[tumors]] of large [[size]] (>5 cm).
-===2. Carcinoid tumor in the lung===
-====Based on histology====
-Carcinoid tumor of the lung may be classified based on the histology into two subtypes:<ref>Carcinoid tumours of the lung. Radiopaedia. http://radiopaedia.org/articles/carcinoid-tumours-of-the-lung</ref>
-*Typical carcinoid tumors of the lung
-*Atypical carcinoid tumors of the lung
-====Based on location====
-Carcinoid tumor of the lung may be classified based on the location into two subtypes:
-*[[Bronchial]] carcinoid tumors: central lesions
-*Peripheral pulmonary carcinoid tumors: peripheral lesions
-===3. Carcinoid tumor in the ovary===
+{{Carcinoid syndrome}}
-Carcinoid tumors of the ovary are divided into four main types:<ref> Ovarian carcinoid tumours
+{| class="wikitable"
-. Radiopaedia (date). http://radiopaedia.org/articles/ovarian-carcinoid-tumours Accessed on September 24, 2015</ref>
+|+<big>Gastroenteropancreatic neuroendocrine tumors</big>
-*Insular type: most common and the only type that is associated with the carcinoid syndrome
+!
-*Trabecular type
+!'''[[Foregut]]'''
-*Strumal type: second commonest type
+!'''[[Midgut]]'''
-*Mucinous type (goblet cell 4)
+!'''[[Hindgut]]'''
+|-
+|'''Location'''
+|
+* [[Stomach]]
+* [[Duodenum]]
+* [[Bronchus]]
+* [[Thymus]]
+|
+* [[Jejunum]]
+* [[Ileum]]
+* [[Appendix]]
+* [[Ascending colon]]
+|
+* [[Transverse colon]]
+* [[Descending colon]]
+* [[Sigmoid colon]]
+* [[Rectum]]
+* [[Genitourinary]]
+|-
+|'''[[Hormones]] produced'''
+|
+* [[5-hydroxytryptophan]]
+* [[Histamine]]
+* [[Multiple polypeptides]]
+|
+* [[Serotonin]]
+* [[Prostaglandins]]
+* [[Polypeptides]]
+|Variable
+|-
+|'''Possibility of [[carcinoid]] [[syndrome]]'''
+|Rare, and atypical when it occurs
+|Classic
+|Rare
+|}
 ==References==
@@ Line 37: / Line 65: @@
 {{WS}}
-[[Category:Disease]]
+[[Category:Gastroenterology]]
-[[Category:Types of cancer]]
 [[Category:Endocrinology]]
+[[Category:Pulmonology]]
+[[Category:Hematology]]
+ [[Category:Up-To-Date]]
+[[Category:Oncology]]
+[[Category:Medicine]]
 [[Category:Gastroenterology]]
+[[Category:Endocrinology]]
+[[Category:Surgery]]

Carcinoid syndrome classification: Difference between revisions

Latest revision as of 20:04, 1 May 2019

Overview

Classification

References

Navigation menu